LSD, 5-HT (serotonin), and the evolution of a behavioral assay

被引:21
作者
Appel, JB
West, WB
Buggy, J
机构
[1] Univ S Carolina, Dept Psychol, Behav Pharmacol Lab, Columbia, SC 29208 USA
[2] Univ S Carolina, Sch Med, Dept Physiol & Pharmacol, Columbia, SC 29208 USA
关键词
LSD; serotonin (5-HT); lisuride (LHM); drug discrimination; rats;
D O I
10.1016/j.neubiorev.2003.11.012
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Research in our laboratory, supported by NIDA and facilitated by Roger Brown, has indicated that serotonergic neuronal systems are involved in the discriminative stimulus effects of LSD. However, the only compounds that fully antagonize the LSD cue act at both serotonin (5-HT) and dopamine (DA) receptors. In addition, substitution for LSD in standard drug vs. no-drug (DND) discriminations does not necessarily predict either similar mechanisms of action or hallucinogenic potency because 'false positives' occur when animals are given drugs such as lisuride (LHM), quipazine, or, possibly, yohimbine. These effects can be greatly reduced by using drug vs. drug (D-D), drug vs. drug vs. no drug (D-ND), or drug vs. 'other' drug (saline, cocaine, pentobarbital) training procedures. Additional studies, in which drugs were administered directly into the cerebral ventricles or specific brain areas, suggest that structures containing terminal fields of serotonergic neurons might be involved in the stimulus effects of LSD. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:693 / 701
页数:9
相关论文
共 30 条
[1]   ANALYZING MECHANISM(S) OF HALLUCINOGENIC DRUG-ACTION WITH DRUG DISCRIMINATION PROCEDURES [J].
APPEL, JB ;
WHITE, FJ ;
HOLOHEAN, AM .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1982, 6 (04) :529-536
[2]   Increasing the selectivity of drug discrimination procedures [J].
Appel, JB ;
West, WB ;
Rolandi, WG ;
Alici, T ;
Pechersky, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 64 (02) :353-358
[3]  
APPEL JB, 1991, NIDA RES MONOGR, V16, P369
[4]  
BURRIS KD, 1991, J PHARMACOL EXP THER, V258, P891
[5]   DIFFERENTIATION BETWEEN THE STIMULUS EFFECTS OF (+)-LYSERGIC ACID DIETHYLAMIDE AND LISURIDE USING A 3-CHOICE, DRUG DISCRIMINATION PROCEDURE [J].
CALLAHAN, PM ;
APPEL, JB .
PSYCHOPHARMACOLOGY, 1990, 100 (01) :13-18
[6]  
COLPAERT FC, 1982, ARCH INT PHARMACOD T, V258, P283
[7]   BEHAVIORAL AND 5-HT ANTAGONIST EFFECTS OF RITANSERIN - A PURE AND SELECTIVE ANTAGONIST OF LSD DISCRIMINATION IN RAT [J].
COLPAERT, FC ;
MEERT, TF ;
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
PSYCHOPHARMACOLOGY, 1985, 86 (1-2) :45-54
[8]  
COLPAERT FC, 1982, J PHARMACOL EXP THER, V221, P206
[9]   NEUROPHARMACOLOGICAL REASSESSMENT OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF D-LYSERGIC-ACID DIETHYLAMIDE (LSD) [J].
CUNNINGHAM, KA ;
APPEL, JB .
PSYCHOPHARMACOLOGY, 1987, 91 (01) :67-73
[10]   PHARMACOLOGICAL CHARACTERIZATION OF DOPAMINE SYSTEMS IN THE NUCLEUS-ACCUMBENS CORE AND SHELL [J].
DEUTCH, AY ;
CAMERON, DS .
NEUROSCIENCE, 1992, 46 (01) :49-56